Medical Scientist Training Program (MSTP)

Medical Scientist Training Program

Thesis Defense

Featured Student

uploadedImages/education/mstp/featured-students/david-gross.jpg

David Gross

Einstein's MSTP streamlines the first year of the program very nicely so that MD-PhDs can have a more productive schedule and an accelerated graduation time. My favorite classes so far are Immunology and Anatomy. MSTP Anatomy has unparalleled individual attention, and Immunology had superb lecturers.

 

The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (Einstein) is one of the nation’s oldest. From the start, our goal has been to train a diverse group of outstanding students to become future leaders of academic medicine and medical research. Continuously funded by the National Institutes of Health since 1964, the Einstein MSTP has 412 illustrious Alumni with careers spanning the spectrum from basic science research to clinical medicine and many variations in between.

Today, the Einstein MSTP is still unique. Larger than most other MSTPs, it fosters a strong academic and social community within the college. While large enough to be an independent academic unit, the program is still small enough to provide students with the individual attention their unique careers require.

The current training program recognizes that the successful physician-scientist training is not simply medical school plus graduate training. The program integrates MSTP-specific courses with medical and graduate courses, during the first two years of preclinical course work. Integration continues in the PhD thesis years through weekly involvement in the MSTP Continuity Clinic and monthly Clinical Pathological Conferences and MSTP Career Paths seminars.

Students have outstanding publications and residency placements.

Awards & Accomplishments

  • Marika Osterbur, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Extra-coding features of mRNA are essential for hERG channel function" (Sponsor, Thomas McDonald, Molecular Pharmacology)
  • Karin Skalina, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Optimization of non-ablative focused ultrasound therapy for tumor immunity" (Sponsor, Chandan Guha, Pathology)
  • Michael Willcockson, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Regulators of the erythroid terminal differentiation decision and their connection to the cell cycle" (Sponsor, Art Skoultchi, Cell Biology)
  • Nelson Gil, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "The molecular basis of receptor-ligand recognition on the immunological synapse" (Sponsor, Andras Fiser, Systems & Computational Biology)
  • Odelya Hartung, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "The role of RBPMS2 in establishing oocyte polarity" (Sponsor, Florence Marlow, Developmental & Molecular Biology)
  • Robert Stanley, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Investigating the role of ARC in hematopoiesis and myeloproliferative neoplasms" (Sponsor, Ulrich Steidl, Cell Biology)
  • Kim Ohaegbulam, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "Tumor expressed B7x accelerates disease and is a novel target for immunotherapy" (Sponsor, Xingxing Zang, Microbiology & Immunology)
  • Jennifer Schloss, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Use of beta cell epitopes in preventing type 1 diabetes in humanized mice" (Sponsor, Teresa DiLorenzo, Microbiology & Immunology)
  • Onyi Uchime, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "Novel investigation of the mechanism of BAX modulation" (Sponsor, Evripidis Gavathiotis, Biochemistry)
  • Cynthia Okoye-Okafor, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "The role of C-MAF in stem cells in leukemia" (Sponsor, Ulrich Steidl, Cell Biology)
  • Philip Campbell, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "Polarized transport in nervous system development and disease in zebrafish" (Sponsor, Florence Marlow, Developmental and Molecular Biology)
  • Ashley Pandolfi, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Unraveling crucial roles of homeobox gene HLX in hematopoiesis and leukemogenesis" (Sponsor, Ulrich Steidl, Cell Biology)
  • Jaime Schneider, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "The Role of Chaperone-Mediated Autophagy In Vivo" (Sponsor, Ana Maria Cuervo, Developmental and Molecular Biology)

 more awards 

Publications

  • publications Silmon de Monerri NC, Yakubu RR, Chen AL, Bradley PJ, Nieves E, Weiss LM, Kim K. The Ubiquitin Proteome of Toxoplasma gondii Reveals Roles for Protein Ubiquitination in Cell-Cycle Transitions. Cell Host Microbe. 2015 Nov.
  • publicationsUchime O, Dai Z, Biris N, Lee D, Sidhu SS, Li S, Lai JR, Gavathiotis E. Synthetic Antibodies Inhibit Bcl-2-associated X Protein (BAX) through Blockade of the N-terminal Activation Site. J Biol Chem. 2015 Nov.
  • publicationsStock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice. J Neuroinflammation. 2015 Nov.
  • publicationsLoPiccolo J, Kim SJ, Shi Y, Wu B, Wu H, Chait BT, Singer RH, Sali A, Brenowitz M, Bresnick AR, Backer JM. Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer. J Biol Chem. 2015 Oct 16.
  • publicationsOkoye-Okafor UC, Bartholdy B, Cartier J, Gao EN, Pietrak B, Rendina AR, Rominger C, Quinn C, Smallwood A, Wiggall KJ, Reif AJ, Schmidt SJ, Qi H, Zhao H, Joberty G, Faelth-Savitski M, Bantscheff M, Drewes G, Duraiswami C, Brady P, Groy A, Narayanagari SR, Antony-Debre I, Mitchell K, Wang HR, Kao YR, Christopeit M, Carvajal L, Barreyro L, Paietta E, Makishima H, Will B, Concha N, Adams ND, Schwartz B, McCabe MT, Maciejewski J, Verma A, Steidl U. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015 Oct 5.
  • publicationsFremont R, Tewari A, Khodakhah K. Aberrant Purkinje cell activity is the cause of dystonia in a shRNA-based mouse model of Rapid Onset Dystonia-Parkinsonism. Neurobiol Dis. 2015 Jun 17.

more publications 

Click here to log in
Medical Scientist Training Program (MSTP)